Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.8/5
Zai Lab Ltd

Zai Lab Ltd (ZLAB US)

139
Analysis
Health CareChina
Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.
more
13 Mar 2023 00:30

“Sudden Death” of Silicon Valley Bank (SVB) - The Impact on China Healthcare

SVB's "sudden death" would affect Chinese healthcare companies. Investors need to reassess the risks of related companies.We don't think SVB’s woes...

Logo
546 Views
Share
08 Mar 2023 01:50

China TMT Update(Mar.8): 9926HK,ZLAB,3690HK: Meituan Closure of Self-Operated Taxi Business (+)

ZLAB:HBM announced Phase III success of FcRn drug treating MG(-) 3690HK:Meituan closure of self-operated taxi business may have 6% benefit to net...

Share
bearishZai Lab Ltd
03 Mar 2023 00:47

[Zai LAB (ZLAB US) Earnings Review]: Pretty Much the Same…Maintain SELL

We maintain ZLAB’s business model is inherently flawed because each blockbuster drug it signed needs comprehensive sales support. As a result,...

Share
02 Mar 2023 01:08

China TME Update (Mar.2) - ZLAB; 9995HK;1877HK

ZLAB: Merck's Keytruda received repeated setbacks on treating prostate cancer, but the result cannot benefit ZLAB(/); 9995HK: RemeGen preannounced...

Share
bearishZai Lab Ltd
11 Jan 2023 12:06

Zai LAB (ZLAB.US/9688.HK):TTF Is Not a Done Deal, Both China and Globally

ZaiLab and NovoCure surged on positive readout of Optune’s Phase III on Non-Small-Cell-Lung Cancer (NSCLC). We, however, caution that Optune faces...

Share
x